nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—PPP3CA—Alzheimers Disease—CACNA1F—refractive error	0.0706	0.0706	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta Receptor Signaling—ZEB2—refractive error	0.039	0.039	CbGpPWpGaD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—PTPRR—refractive error	0.0386	0.0386	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta receptor signaling—RNF111—refractive error	0.0351	0.0351	CbGpPWpGaD
Tacrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—RNF111—refractive error	0.0277	0.0277	CbGpPWpGaD
Tacrolimus—PPP3CA—Alzheimers Disease—CACNA1D—refractive error	0.0271	0.0271	CbGpPWpGaD
Tacrolimus—PPP3CA—beta-catenin independent WNT signaling—VANGL2—refractive error	0.0231	0.0231	CbGpPWpGaD
Tacrolimus—MTOR—Alpha 6 Beta 4 signaling pathway—LAMA2—refractive error	0.021	0.021	CbGpPWpGaD
Tacrolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—GJD2—refractive error	0.02	0.02	CbGpPWpGaD
Tacrolimus—FKBP1A—TGF-beta receptor signaling—PML—refractive error	0.0191	0.0191	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—PTPRR—refractive error	0.0173	0.0173	CbGpPWpGaD
Tacrolimus—MTOR—CDC42 signaling events—RASGRF1—refractive error	0.0152	0.0152	CbGpPWpGaD
Tacrolimus—PPP3CA—Spinal Cord Injury—COL2A1—refractive error	0.0149	0.0149	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—AXL—refractive error	0.0139	0.0139	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by WNT in cancer—WNT10A—refractive error	0.0138	0.0138	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—AXL—refractive error	0.0131	0.0131	CbGpPWpGaD
Tacrolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CACNA1D—refractive error	0.0126	0.0126	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by Wnt—VANGL2—refractive error	0.0122	0.0122	CbGpPWpGaD
Tacrolimus—PPP3CA—T-Cell Receptor and Co-stimulatory Signaling—PTEN—refractive error	0.012	0.012	CbGpPWpGaD
Tacrolimus—FKBP1A—Spinal Cord Injury—COL2A1—refractive error	0.0115	0.0115	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by Wnt—WNT10A—refractive error	0.0113	0.0113	CbGpPWpGaD
Tacrolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.0103	0.0103	CbGpPWpGaD
Tacrolimus—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.0101	0.0101	CbGpPWpGaD
Tacrolimus—MTOR—mTOR signaling pathway—PML—refractive error	0.00889	0.00889	CbGpPWpGaD
Tacrolimus—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—refractive error	0.00881	0.00881	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—RASGRF1—refractive error	0.00851	0.00851	CbGpPWpGaD
Tacrolimus—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00831	0.00831	CbGpPWpGaD
Tacrolimus—MTOR—CDC42 signaling events—PAX6—refractive error	0.00788	0.00788	CbGpPWpGaD
Tacrolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.00741	0.00741	CbGpPWpGaD
Tacrolimus—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00732	0.00732	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—OR2M7—refractive error	0.00695	0.00695	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.00676	0.00676	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IFITM2—refractive error	0.00635	0.00635	CbGpPWpGaD
Tacrolimus—PPP3CA—BCR signaling pathway—PTEN—refractive error	0.00616	0.00616	CbGpPWpGaD
Tacrolimus—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00601	0.00601	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—VIPR2—refractive error	0.00591	0.00591	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—BMP2—refractive error	0.00585	0.00585	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.00554	0.00554	CbGpPWpGaD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.00551	0.00551	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—COL9A1—refractive error	0.0055	0.0055	CbGpPWpGaD
Tacrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—refractive error	0.00543	0.00543	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—GREM2—refractive error	0.00542	0.00542	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—DSE—refractive error	0.00499	0.00499	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—RDH5—refractive error	0.00469	0.00469	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CHN1—refractive error	0.00461	0.00461	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—PML—refractive error	0.00459	0.00459	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—BMP2—refractive error	0.00454	0.00454	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—WNT10A—refractive error	0.00448	0.00448	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PCCA—refractive error	0.00445	0.00445	CbGpPWpGaD
Tacrolimus—CYP3A7—Biological oxidations—CYP26A1—refractive error	0.00442	0.00442	CbGpPWpGaD
Tacrolimus—CYP3A7—Metapathway biotransformation—CYP26A1—refractive error	0.00436	0.00436	CbGpPWpGaD
Tacrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—PDGFRA—refractive error	0.00428	0.00428	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—GREM2—refractive error	0.0042	0.0042	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—OR2M7—refractive error	0.00411	0.00411	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IPO5—refractive error	0.00407	0.00407	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00402	0.00402	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—DSE—refractive error	0.00387	0.00387	CbGpPWpGaD
Tacrolimus—MTOR—PI-3K cascade—PDGFRA—refractive error	0.00386	0.00386	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—RNF111—refractive error	0.00385	0.00385	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—WNT10A—refractive error	0.00378	0.00378	CbGpPWpGaD
Tacrolimus—MTOR—PI3K/AKT activation—PDGFRA—refractive error	0.00377	0.00377	CbGpPWpGaD
Tacrolimus—MTOR—GAB1 signalosome—PDGFRA—refractive error	0.00374	0.00374	CbGpPWpGaD
Tacrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PDGFRA—refractive error	0.00365	0.00365	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—RDH5—refractive error	0.00364	0.00364	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CHN1—refractive error	0.00357	0.00357	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—RNF111—refractive error	0.00355	0.00355	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VIPR2—refractive error	0.00349	0.00349	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PCCA—refractive error	0.00345	0.00345	CbGpPWpGaD
Tacrolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.00345	0.00345	CbGpPWpGaD
Tacrolimus—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.0034	0.0034	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RDH5—refractive error	0.00328	0.00328	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CTSC—refractive error	0.00327	0.00327	CbGpPWpGaD
Tacrolimus—CYP3A5—Biological oxidations—CYP26A1—refractive error	0.00319	0.00319	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—OR2M7—refractive error	0.00318	0.00318	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IPO5—refractive error	0.00315	0.00315	CbGpPWpGaD
Tacrolimus—CYP3A5—Metapathway biotransformation—CYP26A1—refractive error	0.00315	0.00315	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AXL—refractive error	0.00311	0.00311	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—LUM—refractive error	0.00308	0.00308	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—WNT10A—refractive error	0.00293	0.00293	CbGpPWpGaD
Tacrolimus—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—refractive error	0.00289	0.00289	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—PDGFRA—refractive error	0.00288	0.00288	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VANGL2—refractive error	0.00285	0.00285	CbGpPWpGaD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.00283	0.00283	CbGpPWpGaD
Tacrolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00279	0.00279	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFITM2—refractive error	0.00277	0.00277	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—RNF111—refractive error	0.00277	0.00277	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—PDGFRA—refractive error	0.00276	0.00276	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—RNF111—refractive error	0.00276	0.00276	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—PDGFRA—refractive error	0.00272	0.00272	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VIPR2—refractive error	0.00271	0.00271	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—EBP—refractive error	0.00265	0.00265	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—WNT10A—refractive error	0.00265	0.00265	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—PDGFRA—refractive error	0.00259	0.00259	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—PDGFRA—refractive error	0.00258	0.00258	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—PDGFRA—refractive error	0.00257	0.00257	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—PDGFRA—refractive error	0.00256	0.00256	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RDH5—refractive error	0.00255	0.00255	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PDGFRA—refractive error	0.00252	0.00252	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—RPS27—refractive error	0.00249	0.00249	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CER1—refractive error	0.00249	0.00249	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—RNF111—refractive error	0.00249	0.00249	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TJP2—refractive error	0.00249	0.00249	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AXL—refractive error	0.00241	0.00241	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—PDGFRA—refractive error	0.0024	0.0024	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—PDGFRA—refractive error	0.0024	0.0024	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.0024	0.0024	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—LUM—refractive error	0.00239	0.00239	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—PDGFRA—refractive error	0.00238	0.00238	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GREM2—refractive error	0.00236	0.00236	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.00236	0.00236	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CTSC—refractive error	0.00235	0.00235	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—PDGFRA—refractive error	0.00235	0.00235	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—PDGFRA—refractive error	0.00223	0.00223	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VANGL2—refractive error	0.00221	0.00221	CbGpPWpGaD
Tacrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—PTEN—refractive error	0.0022	0.0022	CbGpPWpGaD
Tacrolimus—MTOR—Disease—DSE—refractive error	0.00217	0.00217	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—PDGFRA—refractive error	0.00214	0.00214	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.00213	0.00213	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PML—refractive error	0.0021	0.0021	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.00207	0.00207	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—WNT10A—refractive error	0.00205	0.00205	CbGpPWpGaD
Tacrolimus—MTOR—Disease—RDH5—refractive error	0.00204	0.00204	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CHN1—refractive error	0.00201	0.00201	CbGpPWpGaD
Tacrolimus—MTOR—PI-3K cascade—PTEN—refractive error	0.00198	0.00198	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—PDGFRA—refractive error	0.00197	0.00197	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PCCA—refractive error	0.00194	0.00194	CbGpPWpGaD
Tacrolimus—MTOR—PI3K/AKT activation—PTEN—refractive error	0.00193	0.00193	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—RPS27—refractive error	0.00193	0.00193	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—RNF111—refractive error	0.00193	0.00193	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CER1—refractive error	0.00193	0.00193	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TJP2—refractive error	0.00193	0.00193	CbGpPWpGaD
Tacrolimus—MTOR—GAB1 signalosome—PTEN—refractive error	0.00192	0.00192	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—EBP—refractive error	0.0019	0.0019	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—COL9A1—refractive error	0.00189	0.00189	CbGpPWpGaD
Tacrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—refractive error	0.00187	0.00187	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—PTEN—refractive error	0.00187	0.00187	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—OR2M7—refractive error	0.00179	0.00179	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	0.00179	0.00179	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PCCA—refractive error	0.00179	0.00179	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IPO5—refractive error	0.00177	0.00177	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—RNF111—refractive error	0.00168	0.00168	CbGpPWpGaD
Tacrolimus—MTOR—Disease—WNT10A—refractive error	0.00165	0.00165	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—PDGFRA—refractive error	0.00164	0.00164	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.00164	0.00164	CbGpPWpGaD
Tacrolimus—MTOR—Disease—RNF111—refractive error	0.00155	0.00155	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VIPR2—refractive error	0.00152	0.00152	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—CYP26A1—refractive error	0.00148	0.00148	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—PTEN—refractive error	0.00148	0.00148	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—CYP26A1—refractive error	0.00146	0.00146	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—COL9A1—refractive error	0.00146	0.00146	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—DSE—refractive error	0.00144	0.00144	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RDH5—refractive error	0.00143	0.00143	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CTSC—refractive error	0.00143	0.00143	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—PTEN—refractive error	0.00142	0.00142	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—PTEN—refractive error	0.0014	0.0014	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—PTEN—refractive error	0.00139	0.00139	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—EBP—refractive error	0.00137	0.00137	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AXL—refractive error	0.00136	0.00136	CbGpPWpGaD
Tacrolimus—MTOR—Disease—LUM—refractive error	0.00134	0.00134	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.00134	0.00134	CbGpPWpGaD
Tacrolimus—MTOR—Insulin Signaling—PTEN—refractive error	0.00134	0.00134	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—PTEN—refractive error	0.00133	0.00133	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—PTEN—refractive error	0.00133	0.00133	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.00133	0.00133	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—PTEN—refractive error	0.00132	0.00132	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—PTEN—refractive error	0.00131	0.00131	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	0.00129	0.00129	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—BMP2—refractive error	0.00129	0.00129	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PCCA—refractive error	0.00128	0.00128	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PLA2G16—refractive error	0.00128	0.00128	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PDGFRA—refractive error	0.00125	0.00125	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VANGL2—refractive error	0.00124	0.00124	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—PTEN—refractive error	0.00123	0.00123	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—PTEN—refractive error	0.00123	0.00123	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.00123	0.00123	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—PTEN—refractive error	0.00122	0.00122	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—PTEN—refractive error	0.00121	0.00121	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—PTEN—refractive error	0.00121	0.00121	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—EBP—refractive error	0.00118	0.00118	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—WNT10A—refractive error	0.00115	0.00115	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PDGFRA—refractive error	0.00115	0.00115	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—PTEN—refractive error	0.00114	0.00114	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—PTEN—refractive error	0.0011	0.0011	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.00109	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—Disease—RPS27—refractive error	0.00109	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RNF111—refractive error	0.00109	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TJP2—refractive error	0.00109	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CER1—refractive error	0.00109	0.00109	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—DSE—refractive error	0.00104	0.00104	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—EBP—refractive error	0.00103	0.00103	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—BMP2—refractive error	0.001	0.001	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.000974	0.000974	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—PDGFRA—refractive error	0.000934	0.000934	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—TUBB3—refractive error	0.000933	0.000933	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PLA2G16—refractive error	0.000926	0.000926	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PCCA—refractive error	0.000926	0.000926	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PML—refractive error	0.000914	0.000914	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—PDGFRA—refractive error	0.000897	0.000897	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—DSE—refractive error	0.000895	0.000895	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PDGFRA—refractive error	0.000893	0.000893	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—LUM—refractive error	0.000888	0.000888	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CACNA1D—refractive error	0.000855	0.000855	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—PTEN—refractive error	0.000841	0.000841	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—COL9A1—refractive error	0.000822	0.000822	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—TUBB3—refractive error	0.000818	0.000818	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PDGFRA—refractive error	0.000807	0.000807	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PLA2G16—refractive error	0.000798	0.000798	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PCCA—refractive error	0.000798	0.000798	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DSE—refractive error	0.000784	0.000784	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP26A1—refractive error	0.000755	0.000755	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PLA2G16—refractive error	0.000699	0.000699	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PCCA—refractive error	0.000699	0.000699	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—LUM—refractive error	0.000642	0.000642	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PTEN—refractive error	0.000641	0.000641	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—EBP—refractive error	0.000637	0.000637	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PDGFRA—refractive error	0.000626	0.000626	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CACNA1D—refractive error	0.000618	0.000618	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PTEN—refractive error	0.000591	0.000591	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—BMP2—refractive error	0.000564	0.000564	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—LUM—refractive error	0.000553	0.000553	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP26A1—refractive error	0.000546	0.000546	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PDGFRA—refractive error	0.000544	0.000544	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CACNA1D—refractive error	0.000532	0.000532	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PDGFRA—refractive error	0.000502	0.000502	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.0005	0.0005	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—LUM—refractive error	0.000484	0.000484	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DSE—refractive error	0.000483	0.000483	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—PTEN—refractive error	0.00048	0.00048	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP26A1—refractive error	0.00047	0.00047	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CACNA1D—refractive error	0.000466	0.000466	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—PTEN—refractive error	0.000461	0.000461	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTEN—refractive error	0.000459	0.000459	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PCCA—refractive error	0.000431	0.000431	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLA2G16—refractive error	0.000431	0.000431	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PTEN—refractive error	0.000414	0.000414	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP26A1—refractive error	0.000412	0.000412	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PDGFRA—refractive error	0.000352	0.000352	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PTEN—refractive error	0.000321	0.000321	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—LUM—refractive error	0.000298	0.000298	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CACNA1D—refractive error	0.000287	0.000287	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PTEN—refractive error	0.000279	0.000279	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTEN—refractive error	0.000258	0.000258	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP26A1—refractive error	0.000254	0.000254	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTEN—refractive error	0.000238	0.000238	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTEN—refractive error	0.000181	0.000181	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTEN—refractive error	0.00017	0.00017	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTEN—refractive error	0.000123	0.000123	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTEN—refractive error	0.000106	0.000106	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTEN—refractive error	9.3e-05	9.3e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTEN—refractive error	5.73e-05	5.73e-05	CbGpPWpGaD
